5 h. ago Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL

SHANGHAI, Dec. 05, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the new drug application (“NDA”) for the company’s product, roconkibart injection (a recombinant humanized anti-IL-17A monoclonal antibody injection, product code: […]

Culture

23 h. ago Trisura Group Ltd. Announces Renewal of Normal Course Issuer Bid

TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, announced today that the Toronto Stock Exchange (“TSX”) has accepted a notice filed by Trisura Group Ltd. of its intention to renew its Normal Course Issuer Bid (“NCIB”) to be transacted through the facilities […]

Other

32 h. ago NEUPATH HEALTH ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID

TORONTO — NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the “Company”) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice filed by NeuPath of its intention to renew its normal course issuer bid (“NCIB”). Under the NCIB, the Company may, during the 12-month period commencing December 4, 2025 and ending December 3, […]

Science

1 week ago Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST

SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the JS001sc-002-III-NSCLC study has met its primary endpoints. JS001sc-002-III-NSCLC is a multi-center, open-label, randomized Phase 3 clinical study comparing toripalimab […]

Politics

2 w. ago The North West Company Inc. Announces Renewal of its Normal Course Issuer Bid

WINNIPEG, Manitoba, Nov. 20, 2025 (GLOBE NEWSWIRE) — (TSX: NWC): The North West Company Inc. (the “Company” or “North West”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted notice of the Company’s intention to make a normal course issuer bid (“NCIB”) for a portion of its common voting shares and variable voting shares […]

Economics

2 w. ago Choice Properties Real Estate Investment Trust Announces Normal Course Issuer Bid

TORONTO — (TSX: CHP.UN) – Choice Properties Real Estate Investment Trust (“Choice Properties” or the “Trust”) announced today that the Toronto Stock Exchange (“TSX”) has accepted a notice filed by Choice Properties of its intention to make a normal course issuer bid (“NCIB”). The TSX notice provides that Choice Properties may, during the 12-month period […]

Other